Immutep Ltd Files 6-K Report
Ticker: PRRUF · Form: 6-K · Filed: Dec 10, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Dec 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulatory, foreign-private-issuer
TL;DR
IMMUTEP files routine 6-K, confirms 20-F reporting.
AI Summary
Immutep Limited filed a Form 6-K on December 10, 2024. The filing is a report of a foreign private issuer and indicates that the company files annual reports under Form 20-F. Immutep Limited is incorporated in Australia and its principal executive office is located in Sydney.
Why It Matters
This filing provides routine disclosure for Immutep Ltd as a foreign private issuer, informing investors about its reporting status and corporate details.
Risk Assessment
Risk Level: low — This is a standard procedural filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- IMMUTEP Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- December 10, 2024 (date) — Filing date
- Sydney NSW 2000, Australia (location) — Principal executive office address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. It is used to furnish information which the registrant may be required to make public pursuant to the laws of its home country or which it may publish or file with its home country exchange.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is December 10, 2024.
What is the principal executive office address of Immutep Limited?
The principal executive office address of Immutep Limited is Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Does Immutep Limited file its annual reports under Form 20-F or Form 40-F?
Immutep Limited indicates that it files its annual reports under cover of Form 20-F.
What was Immutep Limited's former company name?
Immutep Limited's former company name was Prima BioMed Ltd.
Filing Stats: 261 words · 1 min read · ~1 pages · Grade level 17.1 · Accepted 2024-12-10 17:26:25
Filing Documents
- d785742d6k.htm (6-K) — 9KB
- d785742dex991.htm (EX-99.1) — 7KB
- g785742g30z01.jpg (GRAPHIC) — 7KB
- 0001193125-24-274437.txt ( ) — 28KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 10, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer